Home | Welcome to Contract Pharma   
Last Updated Friday, August 1 2014
Print

Search Results for 'Biogen Acquires Full Tysabri Rights'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

By Kristin Brooks
Published January 29, 2014
Expanded MS franchise drives growth Read More »
Published October 24, 2013
Records $12.1 million in Tysabri royalties in the quarter Read More »
SPR & Flow Cytometry For Biosimilars
By James Hulse, Ph.D. and Chris Cox, Ph.D. , EMD Millipore
Published May 6, 2013
Evaluating the pharmacodynamics of biosimilar monoclonal antibodies Read More »
Published February 6, 2013
Elan to receive $3.25 billion, royalties Read More »
Top 50 (or so) Biopharma Products
By Ronald A. Rader
Published July 18, 2012
Ranking the top 57 biopharma products by 2011 revenues Read More »
Published September 29, 2011
Kingsley will oversee global commercial business strategies Read More »
Complying with Track and Trace
By Stephen Barlas
Published April 30, 2008
Biogen Idec blazes a path to California compliance Read More »
By Bob Muschert, Global Sales & Business Development Director
By Jerome BESSE, CEO
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On